Says 10 Phase 3 trials with PF’3944 expected to advance in 2026; expansive clinical development program underway with 20+ planned and ongoing studies across diverse obesity pipeline.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- These Are the Stocks Reporting Earnings Today – February 3, 2026
- Is Pfizer (PFE) a Good Stock to Buy before Earnings?
- Bullish flow in Pfizer with shares up 0.17%
- Notable companies reporting before tomorrow’s open
- Options Volatility and Implied Earnings Moves This Week, February 02 – February 06, 2026